Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging

Completed · Not applicable

Conditions studied: Photoaging

In brief

Photoaging is a common concern within the cosmeceutical industry with many products that are available. One frequently used product is hydroquinone that is used to even skin tone. However, hydroquinone has several shortcomings. The ingredient is controversial for its potential safety issues and it has been banned in Europe. An alternative ingredient that has emerged for its potential use is hexyresorcinol for evening skin tone. Additionally, hexylresorcinol may have other photoaging benefits such as the reduction in the appearance of fine lines. Therefore, the aim of this study is to assess how hexyresorcinol may compare to the use of hydroquinone in the setting of photoaging.

Key facts

Study ID
NCT04345094
Run by
Sytheon Ltd.
People needed
32
Starts
2019-07-01
Expected to finish
2020-02-15
Last updated by the study team
2020-07-10

Who can join

Age: 35 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.